U.S. coronavirus cases rise, fueling fears of resurgence

By Maria Caspani

NEW YORK (Reuters) – A rapid increase in coronavirus cases in the United States and abroad is fueling fears of a pandemic resurgence and sending shockwaves through the stock market as the highly contagious Delta variant takes hold and vaccinations lag in several states.

Largely due to outbreaks in parts of the country with low vaccination rates, the number of new cases, hospitalizations and deaths due to COVID-19 have been on the rise in recent weeks.

The vaccines work against the Delta variant, but lab tests have shown them to be less effective than they were against the original form of coronavirus.

Studies have also shown that two shots of the Pfizer/BioNTech vaccine and of the AstraZeneca vaccine are much more effective than one shot against being infected with the virus, making it more important for people to be fully vaccinated.

Concerns the outbreaks could derail an economic recovery sent the Dow down more than 2% on Monday.

In a speech about the U.S. economy, President Joe Biden said the recovery hinges on getting the pandemic under control. He said four states with low vaccination rates accounted for 40% of all cases last week.

“So please, please get vaccinated,” Biden said. “Get vaccinated now.”

The average number of new COVID-19 cases per day has tripled in the past 30 days in the United States, according to an analysis of Reuters data. In the month from June 18 to Sunday, it climbed from 12,004 to 32,136.

The average number of people hospitalized with COVID-19 has gone up 21% over the past 30 days to over 19,000, up from 16,000, according to the same Reuters analysis.

Deaths, which can lag weeks behind a rise in cases, rose 25% last week from the previous seven days with an average of 250 people dying a day.

Some states have been especially hard hit. All but two of the 75 Arkansas counties have substantial or high levels of transmission, according to data from the U.S. Centers for Disease Control and Prevention (CDC).

But even in states with higher vaccination rates, such as New York, officials have expressed concern about fresh outbreaks, pointing to the significantly more contagious Delta variant.

So far, the variant has been detected around 100 countries globally and is now the dominant variant worldwide, top U.S. infectious disease expert Anthony Fauci told reporters last week.

In California, Los Angeles County reimposed a mask mandate at the weekend. It followed six straight days of more than 1,000 new COVID-19 cases in the county, with nearly 400 people hospitalized with COVID-19 as of Wednesday, up 275 from the week before.

While New York City Mayor Bill de Blasio acknowledged a rise in the number of cases, he told a daily news conference on Monday there were no plans to reintroduce mask mandates. He vowed instead to redouble vaccination efforts.

Overseas, COVID-19 restrictions are being reimposed in countries experiencing worrying spikes. The Netherlands announced it was re-imposing work-from-home guidelines due to soaring COVID-19 infections, just weeks after lifting them, as well as some restrictions on bars, restaurants and nightclubs.

Britain ended over a year of COVID-19 lockdown restrictions on Monday but the so-called “Freedom Day” was marred by surging infections and grim forecasts.

The U.S. Centers for Disease Control and Prevention on Monday issued a more severe warning against travel to the United Kingdom, elevating the nation to “Level Four: COVID-19 Very High,” the CDC’s highest level.

(Reporting by Maria Caspani in New York; Additional reporting by Anurag Maan, Sharon Bernstein and Caroline Humer; Editing by Howard Goller)

What you need to know about the coronavirus right now 6-12-20

(Reuters) – Here’s what you need to know about the coronavirus right now:

Second-wave fears

Governors of U.S. states that are COVID-19 hotspots pressed ahead with economic reopenings that have raised fears of a second wave of infections.

The moves by states such as Florida and Arizona came as Treasury Secretary Steven Mnuchin said the United States could not afford to let the novel coronavirus shut its economy again and global stocks tanked on worries of a pandemic resurgence.

In Europe, health experts said the risk of a second wave of COVID-19 infections big enough to require lockdowns to be reimposed is moderate to high.

India reported a record daily increase of cases and became the world’s fourth worst-hit country, raising the prospect of the return of a lockdown just days after it was lifted.

Insurers beat back virus claims

U.S. property and casualty insurers have cast the coronavirus pandemic as an unprecedented event whose cost to small businesses they are neither able nor required to cover.

The industry has warned it could cost them $255 billion to $431 billion a month if they are required, as some states are proposing, to compensate firms for income lost and expenses owed due to virus-led shutdowns, an amount it says would make insurers insolvent.

A Reuters examination of the estimate, however, suggests the possible bill may not be so onerous.

British economy battered

The UK economy shrank by a quarter in the March-April period as entire sectors were shuttered by the coronavirus lockdown.

“This is catastrophic, literally on a scale never seen before in history,” Paul Johnson, director of the Institute for Fiscal Studies think tank, said. “The real issue is what happens next.”

The Organisation for Economic Co-operation and Development says Britain – with its huge services industries that are hit hard by social distancing measures – could suffer the worst downturn among the countries it covers, with an 11.5% contraction this year.

Bottlenecks? Glass vial makers prepare for vaccine

Drugmakers are warning of a potential shortage of vials to bottle future COVID-19 vaccines, but their rush to secure supplies risks making matters worse.

Schott AG, the world’s largest maker of speciality glass for vaccine vials, says it has turned down requests to reserve output from major pharmaceutical firms because it does not want to commit resources before it is clear which vaccines will work.

“We have to keep the door open to give capacity to those who really are successful in the end. We don’t want to be portrayed in the press as the ones who were unable to package the best vaccine,” Chief Executive Frank Heinricht told Reuters.

Roping in the drones

Airspace Systems, a California startup company that makes drones that can hunt down and capture other drones, on Thursday released new software for monitoring social distancing and protective face-mask wearing from the air.

The software analyzes video streams captured by drones and can identify when people are wearing masks, standing close together or points where people gather in clusters. Airspace aims to sells the system to cities and police departments.

The company says the system does not use facial recognition and does not save images of people or pass those images to its customers. Even with those protections in place, the system is still “a step toward robots that are monitoring our behavior,” said Jay Stanley, a senior policy analyst with the American Civil Liberties Union’s Speech, Privacy and Technology Project.

(Compiled by Linda Noakes, Editing by Timothy Heritage)